» Articles » PMID: 35268466

The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Mar 10
PMID 35268466
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of nonalcoholic fatty liver disease (NAFLD) is growing worldwide. Epidemiological data suggest a strong relationship between NAFLD and T2DM. This is associated with common risk factors and pathogenesis, where obesity, insulin resistance and dyslipidemia play pivotal roles. Expanding knowledge on the coexistence of NAFLD and T2DM could not only protect against liver damage and glucotoxicity, but may also theoretically prevent the subsequent occurrence of other diseases, such as cancer and cardiovascular disorders, as well as influence morbidity and mortality rates. In everyday clinical practice, underestimation of this problem is still observed. NAFLD is not looked for in T2DM patients; on the contrary, diagnosis for glucose metabolism disturbances is usually not performed in patients with NAFLD. However, simple and cost-effective methods of detection of fatty liver in T2DM patients are still needed, especially in outpatient settings. The treatment of NAFLD, especially where it coexists with T2DM, consists mainly of lifestyle modification. It is also suggested that some drugs, including hypoglycemic agents, may be used to treat NAFLD. Therefore, the aim of this review is to detail current knowledge of NAFLD and T2DM comorbidity, its prevalence, common pathogenesis, diagnostic procedures, complications and treatment, with special attention to outpatient clinics.

Citing Articles

The effect of empagliflozin on non-alcoholic fatty liver disease-related parameters in patients with type 2 diabetes mellitus: a randomized controlled trial.

Shojaei F, Erfanifar A, Kalbasi S, Nikpour S, Gachkar L BMC Endocr Disord. 2025; 25(1):52.

PMID: 40011855 PMC: 11863618. DOI: 10.1186/s12902-025-01882-8.


Metformin: Beyond Type 2 Diabetes Mellitus.

Ahmad R, Haque M Cureus. 2024; 16(10):e71730.

PMID: 39421288 PMC: 11486535. DOI: 10.7759/cureus.71730.


Association of gene Pro512Ala polymorphism with nonalcoholic fatty liver disease.

Asadi A, Rostami M, Shafiee R, Ardalani A, Dehghanitafti A, Golshadi Z Arch Endocrinol Metab. 2024; 68:e230216.

PMID: 39420901 PMC: 11460970. DOI: 10.20945/2359-4292-2023-0216.


Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021.

Yang Z, Li A, Jiang Y, Maidaiti X, Wu Y, Jin Y Sci Rep. 2024; 14(1):22232.

PMID: 39333707 PMC: 11437073. DOI: 10.1038/s41598-024-72795-0.


FPS-ZM1 attenuates the deposition of lipid in the liver of diabetic mice by sterol regulatory element binding protein-1c.

Zhang M, Zhao W, Zhang Z, He M, Zhang Y, Song B BMC Endocr Disord. 2024; 24(1):164.

PMID: 39210356 PMC: 11360499. DOI: 10.1186/s12902-024-01705-2.


References
1.
Dubuquoy C, Burnol A, Moldes M . PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function?. Clin Res Hepatol Gastroenterol. 2012; 37(1):30-5. DOI: 10.1016/j.clinre.2012.06.014. View

2.
Lin X, Li J, Ying M, Wei F, Xie X . Diabetes Increases Morbidities of Colonic Diverticular Disease and Colonic Diverticular Hemorrhage: A Systematic Review and Meta-Analysis. Am J Ther. 2017; 24(2):e213-e221. DOI: 10.1097/MJT.0000000000000410. View

3.
Hu H, Lin A, Kong M, Yao X, Yin M, Xia H . Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. J Gastroenterol. 2019; 55(2):142-158. PMC: 6981320. DOI: 10.1007/s00535-019-01649-8. View

4.
El-Serag H, Tran T, Everhart J . Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004; 126(2):460-8. DOI: 10.1053/j.gastro.2003.10.065. View

5.
Bonapace S, Perseghin G, Molon G, Canali G, Bertolini L, Zoppini G . Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care. 2012; 35(2):389-95. PMC: 3263884. DOI: 10.2337/dc11-1820. View